Jiamei Chen
Key Laboratory Of Liver And Kidney Diseases
Shuguang, China
Shuguang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Correction: The novel Chinese medicine JY5 formula alleviates hepatic fibrosis by inhibiting the notch signaling pathway.
Journal: Frontiers in pharmacology
Published: April 13, 2026
Salvianolic acid B ameliorates metabolic dysfunction-associated steatohepatitis in mice by inhibiting hepatocyte ferroptosis via regulation of the SIRT1/p53 axis.
Journal: Free radical biology & medicine
Published: January 15, 2026
Fuzheng Huayu formula attenuates ductular reaction and liver fibrosis potentially through suppressing Gli1 pathway.
Journal: Journal of ethnopharmacology
Published: December 23, 2025
Synergistic amelioration of cholestatic liver fibrosis by combined total astragalus saponins and AAV8.Numb-Exon3 through modulation of hepatic progenitor cell differentiation.
Journal: Frontiers in pharmacology
Published: December 07, 2025
Isoastragaloside II modulates PPAR-α/FXR signaling and bile acid metabolism to ameliorate cholestatic liver diseases (CLD).
Journal: European journal of pharmacology
Published: December 01, 2025
In Situ Lighting-Up Near-Infrared Metabolic Probes for Super-Resolution Imaging of Glycogen.
Journal: ACS sensors
Published: March 11, 2025
Corrigendum to "Schisantherin A protects hepatocyte via upregulating DDAH1 to ameliorate liver fibrosis in mice" [Phytomedicine, 2024, 124: 155330].
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: September 01, 2024
Isoastragaloside I attenuates cholestatic liver diseases by ameliorating liver injury, regulating bile acid metabolism and restoring intestinal barrier.
Journal: Journal of ethnopharmacology
Published: April 27, 2024
Total astragalus saponins attenuate primary sclerosing cholangitis in mice by upregulation of TGR5.
Journal: Phytotherapy research : PTR
Published: November 29, 2023
Recent progress on the application of compound formulas of traditional Chinese medicine in clinical trials and basic research in vivo for chronic liver disease.
Journal: Journal of ethnopharmacology
Published: September 19, 2023
Last Updated: 09/26/2026